Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years.

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Abstract Text:

Douglas E Mattox,Mary Reichert,Douglas E Mattox,Mary Reichert,

OBJECTIVE:: To review the continued use of the Meniett device 2 and 3 years after the device's initial prescription. STUDY DESIGN:: Retrospective case series. SETTING:: Tertiary referral center. PATIENTS:: Patients fitting American Academy of Otolaryngology-Head and Neck Surgery criteria for Ménière's disease who had failed conventional medical therapy between February2002 and April 2004 and who were ready for surgical intervention. INTERVENTION:: Patients used the Meniett device as a nonsurgical alternative for Ménière's management. OUTCOME MEASURES: Continued use or non-use of the device. RESULTS: Twenty-three patients were prescribed and obtained the Meniett device in the study interval. At 2 years of minimum follow-up, there were 21 evaluable patients. Eleven patients (52%) continued to use the device and have good control of vertiginous symptoms at 2+ years. Four patients (19%) were asymptomatic at 1 year and discontinued the use of the device. Six patients (29%) had no impact on their Ménière's symptoms and stopped using the device within the first 3 months. At 3 years of minimum follow-up, there were 19 evaluable patients; of whom, 63% were either using the device or had become asymptomatic. No complications were attributable to the device. CONCLUSION: We conclude that the Meniett device is a useful minimally invasive alternative in the management of Ménière's disease. Among these patients who had failed previous medical management, 71% and 63% required no additional intervention beyond the Meniett device at a minimum of 2 and 3 years of follow-up, respectively. Most patients who failed to gain benefit did so early on in therapy.

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Publishing Authors By Initials

DE Mattox,M Reichert,DE Mattox,M Reichert,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Otology & neurotology : official publication of th

VOLUME: 29

Page Numbers: 29-32

Journal Abbreviation: Otol. Neurotol.

ISSN: 1531-7129

DAY: 17

MONTH: Jan

YEAR: 2008

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100961504

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years.

AFFILIATION: Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, U.S.A.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Otol Neurotol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years Related Publications

• Aldehyde dehydrogenase inhibitors: alpha,beta-Acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in culture.
• Amplification of neural stem cell proliferation by intermediate progenitor cells in Drosophila brain development.
• Cell lineage-specific expression and function of the empty spiracles gene in adult brain development of Drosophila melanogaster.
• CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.
• Constipation in infants and young children.
• Current views on the mechanism of oncogenic cell transformation in ovine pulmonary adenocarcinoma.
• Cystocele, rectocele, and hemorrhoids.
• Glucose recovery with bare and hydrogel-coated microdialysis probes: experiment and simulation of temporal effects.
• Headache, tics and neuralgias of the head.
• Human leukocyte antigen polymorphism in chronic and aggressive periodontitis among Caucasians: a meta-analysis.
• Improving endothelial cell adhesion to vascular graft surfaces: clinical need and strategies.
• Intermediate motions as studied by solid-state separated local field NMR experiments.
• Meniett Device for Ménière's Disease: Use and Compliance at 3 to 5 Years.
• Molecular modeling of hexakis(areneisonitrile)technetium(I), tricarbonyl eta5 cyclopentadienyl technetium and technetium(V)-oxo complexes: MM3 parameter development and prediction of biological properties.
• Response of monocytes exposed to phagocytosable particles and discs of comparable surface roughness.
• Retirement.
• Ruptured sinus Valsalva aneurysm, a rare cause of heart failure.
• Species differences in luteinizing hormone as infered from slope variations in a radioligand receptor assay.
• Streptavidin binding and endothelial cell adhesion to biotinylated fibronectin.
• The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes.
• The urbilaterian brain: developmental insights into the evolutionary origin of the brain in insects and vertebrates.
• Traumatic dislocation of the globe into the maxillary sinus.
• Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response.
• Water-soluble treatments to enhance glucose permeability of protein-resistant polymer overlayers.
• [Acute pulmonary embolism--are vena cava interruption procedures and extracorporeal circulation always necessary?]
• [Burn sequelae of the hand and face, when full-thickness skin transplant, when flap?]
• [Functional reconstruction by neurovascular muscle and myocutaneous flaps of the lower extremity]
• [Studies on the sulfonation products of bituminous shale oil.]
• [The importance of dental-based treatment shown on the case report of a pontine abscess caused by Streptococcus viridans.]
• [Transformation of beta-keto bases with o-nitrobenzaldehyde.]